Physician profile
Christopher Browning
NPI 1427156983
$28,379.56
in general payments reported to CMS, 2019-2025
17 companies · $4,285 in 2025
The $4,285 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,796 · 2020: $1,251 · 2021: $4,657 · 2022: $3,408 · 2023: $3,682 · 2024: $6,302 · 2025: $4,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $1,496 · Travel and Lodging: $1,446 · Entertainment: $427 · Gift: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,500.00 |
| Food and Beverage | $1,495.98 |
| Travel and Lodging | $1,445.96 |
| Entertainment | $426.81 |
| Gift | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $14,603.81 | 2019-2025 | Dailies Total1, Precision 1, Air Optix Color |
| Coopervision INC. | $9,376.96 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Paragon Crt |
| Carl Zeiss Meditec USA, INC. | $1,646.72 | 2025 | |
| Optos, INC. | $838.83 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Visionary Optics LLC | $400.00 | 2025 | |
| Lombart Brothers, INC. | $322.48 | 2019-2024 | Opd-III |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $264.62 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $245.02 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $156.06 | 2022-2025 | Infuse |
| Allergan, INC. | $150.90 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $145.80 | 2025 | Xdemvy |
| Dompe US, INC. | $97.46 | 2024 | Oxervate |
| Glaukos Corporation | $87.45 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.33 | 2025 | |
| Abbvie INC. | $14.56 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $13.56 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.